ACTATED RINGER’S SOLUTION IN COMBINATION WITH RECTAL INDOMETHACIN FOR PREVENTION OF POST-ERCP PANCREATITIS: A PROSPECTIVE RANDOMIZED, DOUBLE-BLINDED, CONTROLLED TRIA

Not Applicable

• Conditions: Digestive System

• Registration Number: PACTR202201712208274
• Lead Sponsor: Mohammed seghir nekache hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-26
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 210

Inclusion Criteria

historical criterion of high risk for PEP before the procedure.
major criteria included 1 of the following:
suspicion for sphincter of Oddi dysfunction,
personal history of PEP,
more than 8 cannulation attempts,
precut sphincterotomy,
endoscopic papillary balloon dilation of an intact sphincter,
endoscopic PD sphincterotomy.
Patients were also included if they met 2 or more of the following minor criteria:
female sex and age under 50 years,
personal history of recurrent acute pancreatitis,
PD injection leading to acinarization” or over 3 PD injections, and PD cytology acquisition.

Exclusion Criteria

age under 18 years,
pregnancy,
active acute pancreatitis.
true documented allergy to or use in the day of the procedure of NSAIDs,
acute renal failure,
active peptic ulcer disease.
Contraindications to aggressive IVF hydration.

Study & Design

• Study Type: Interventional
• Study Design: Not specified